公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1997 | Blood-bank screening for hepatitis G [14] | JIA-HORNG KAO ; PEI-JER CHEN ; JIN-TOWN WANG ; Lai M.-Y.; DING-SHINN CHEN | Lancet | 7 | 5 | |
2018 | Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan | Hsieh M.-H.; Yeh M.-L.; TUNG-HUNG SU ; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; CHUN-JEN LIU ; Yu M.-L. | Journal of the Formosan Medical Association | 5 | 4 | |
2024 | Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B | Cheng, Pin-Nan; Feng, I-Cher; Chen, Jyh-Jou; Kuo, Hsing-Tao; Lee, Pei-Lun; Yu, Ming-Lung; Chiu, Yen-Cheng; Chiu, Hung-Chih; Chien, Shih-Chieh; PEI-JER CHEN ; CHUN-JEN LIU | Alimentary pharmacology & therapeutics | 2 | 0 | |
2009 | Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway | Chen K.-F.; Yeh P.-Y.; CHIUN HSU ; CHIH-HUNG HSU ; YEN-SHEN LU ; Hsieh H.-P.; PEI-JER CHEN ; ANN-LII CHENG | Journal of Biological Chemistry | 89 | 84 | |
2011 | Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A | Chen K.-F.; Yu H.-C.; Liu C.-Y.; Chen H.-J.; Chen Y.-C.; Hou D.-R.; PEI-JER CHEN ; ANN-LII CHENG | Molecular Cancer Therapeutics | 36 | 32 | |
1998 | Brief communication: Efficacy of ribavirin plus interferon α on viraemia of GB virus-C/hepatitis G virus: Comparison with interferon α alone | JIA-HORNG KAO ; Lai M.-Y.; Chen W.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 10 | 10 | |
2011 | Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan | PEI-JER CHEN ; Lin J.-J.; Lu C.-S.; Ong C.-T.; Hsieh P.F.; Yang C.-C.; Tai C.-T.; Wu S.-L.; Lu C.-H.; Hsu Y.-C.; Yu H.-Y.; Ro L.-S.; Lu C.-T.; Chu C.-C.; Tsai J.-J.; Su Y.-H.; Lan S.-H.; Sung S.-F.; Lin S.-Y.; Chuang H.-P.; Huang L.-C.; Chen Y.-J.; Tsai P.-J.; Liao H.-T.; Lin Y.-H.; Chen C.-H.; Chung W.-H.; Hung S.-I.; Wu J.-Y.; Chang C.-F.; Chen L.; Chen Y.-T.; Shen C.-Y. | New England Journal of Medicine | 578 | 496 | |
1996 | Casein kinase II and protein kinase C modulate hepatitis delta virus RNA replication but not empty viral particle assembly | Yeh T.-S.; Lo S.J.; PEI-JER CHEN ; Lee Y.-H.W. | Journal of Virology | 40 | 39 | |
2019 | Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development | Hu J.; Lin Y.-Y.; PEI-JER CHEN ; Watashi K.; Wakita T. | Gastroenterology | 66 | 68 | |
2020 | Cell-Free Virus-Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer | Li C.-L.; MING-CHIH HO ; Lin Y.-Y.; Tzeng S.-T.; Chen Y.-J.; Pai H.-Y.; Wang Y.-C.; CHI-LING CHEN ; Lee Y.-H.; Chen D.-S.; Shiou-Hwei Yeh ; PEI-JER CHEN | Hepatology | 30 | 24 | |
1992 | Cellular Immune Response to HBcAg in Mother‐to‐Infant Transmission of Hepatitis B Virus | HONG-YUAN HSU ; MEI-HWEI CHANG ; Hsieh K. H.; CHIN-YUN LEE ; HO-HSIUNG LIN ; Hwang L. H.; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology | 113 | 94 | |
2024 | Challenges for hepatitis B control in Asia-Pacific areas: Consolidating vaccination and rolling-out antiviral therapies | PEI-JER CHEN | Journal of gastroenterology and hepatology | | | |
1990 | Changes of serum hepatitis B virus DNA and aminotransferase levels during the course of chronic hepatitis B virus infection in children | PING-ING LEE ; MEI-HWEI CHANG ; CHIN-YUN LEE ; HONG-YUAN HSU ; Chen J.-S.; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology | | | |
2022 | Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV | CHUN-JEN LIU ; PEI-JER CHEN | Liver International | 12 | 9 | |
2021 | Chapter XX Antiviral Treatment and Cancer Control | WEI-LIANG SHIH ; CHI-TAI FANG ; PEI-JER CHEN | Recent Results in Cancer Research | 0 | 0 | |
1991 | Characterization and genetic analysis of alternatively spliced transcripts of hepatitis B virus in infected human liver tissues and transfected HepG2 cells | Wu H.-L.; PEI-JER CHEN ; Tu S.-J.; Lin M.-H.; Lai M.-Y.; DING-SHINN CHEN | Journal of Virology | 72 | 69 | |
2002 | Characterization of integration patterns and flanking cellular sequences of hepatitis B virus in childhood hepatocellular carcinomas | Tsuei D.-J.; MEI-HWEI CHANG ; PEI-JER CHEN ; Hsu T.-Y.; YEN-HSUAN NI | Journal of Medical Virology | 21 | 14 | |
2009 | Characterization of interleukin 8 in woodchucks with chronic hepatitis B and hepatocellular carcinoma | CHUN-JEN LIU ; Huang Y.-J.; HUEY-LING CHEN ; Lin H.-T.; Lin H.-L.; Kuo M.-L.; Huang J.-L.; DING-SHINN CHEN ; PEI-JER CHEN ; Wu H.-L. | Genes and Immunity | 4 | 5 | |
2016 | Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model | Li Y.-T.; CHUN-JEN LIU ; TUNG-HUNG SU ; Cheng H.-R.; YUNG-MING JENG ; Lin H.-L.; Wang C.-C.; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Wu H.-L. | Oncotarget | 4 | 4 | |
1999 | Characterization of monoclonal antibodies against hepatitis C virus nonstructural protein 3: Different antigenic determinants from human B cells | Ou-Yang P.; BOR-LUEN CHIANG ; Hwang L.-H.; Chen Y.-G.; PEI-MING YANG ; Chi W.-K.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Medical Virology | 7 | | |